Antitumor effect of folate-targeted liposomal doxorubicin in KB tumor-bearing mice after intravenous administration

By Riviere Kareen   Huang Zhaohua   Jerger Katherine   Macaraeg Nichole   Szoka Francis C.  

Journal of Drug Targeting, Vol. 19, Iss. 1, 2011-01 ,pp. : 14-24

Informa Healthcare

Access to resources Recommend Favorite

Bio-distribution and anti-tumor efficacy of PEG/PLA nano particles loaded doxorubicin

By Yu J. J.   Lee H. A.   Kim J. H.   Kong W. H.   Kim Y.   Cui Z. Y.   Park K. G.   Kim W. S.   Lee H. G.   Seo S. W.  

Journal of Drug Targeting, Vol. 15, Iss. 4, 2007-05 ,pp. : 279-284

Informa Healthcare

Access to resources Recommend Favorite

Optimizing Antitumor Efficacy and Adverse Effects of Pegylated Liposomal Doxorubicin by Scheduled Plasmapheresis: Impact of Timing and Dosing

By  

Current Drug Delivery, Vol. 15, Iss. 9, 2018-11 ,pp. : 1261-1270

Bentham Science Publishers

Access to resources Recommend Favorite

Boswellic acids synergize antitumor activity and protect against the cardiotoxicity of doxorubicin in mice bearing Ehrlich’s carcinoma

By  

Canadian Journal of Physiology and Pharmacology, Vol. 93, Iss. 8, 2015-01 ,pp. : 695-708

NRC Research Press

Access to resources Recommend Favorite

Ultrasound enhanced antitumor activity of liposomal doxorubicin in mice

By Hagtvet Eirik   Evjen Tove J.   Olsen Dag Rune   Fossheim Sigrid L.   Nilssen Esben A.  

Journal of Drug Targeting, Vol. 19, Iss. 8, 2011-09 ,pp. : 701-708

Informa Healthcare

Access to resources Recommend Favorite